By the Numbers: Pfizer’s $15 billion payday

Drugmaker Pfizer expects $15 billion in revenue from its COVID-19 vaccine in 2021 and said it can produce 2 billion doses this year, including 200 million doses for the U.S.
1:14 | 02/03/21

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for By the Numbers: Pfizer’s $15 billion payday
Now to the news from finds in the first drug maker along with its partner bio intact to receive US authorization for a company nineteen vaccine. Here's what's next by the numbers fifteen billion dollars us revenue advisor says it expects from its come in nineteen vaccine in 20/20 one based on existing contracts. And that's likely underestimated because the company now says it can produce two billion vaccine doses this year far above what's been contract did. That includes 200 million doses of Pfizer promises for the US by the end of may. 154. Million dollars was Pfizer's revenue from the company's nineteen vaccine in 20/20 that was just the early days of the roll out. Why are accepted zero federal government money into developing manufacturing and still the vaccine but it did enter a multi billion dollar advance purchase deal. With a child administration's operation warp speed. And finally took that fifteen billion of revenue into perspective. I Serb holdings six and a half billion dollars from all of its vaccines in 20/20 so they're expected to more than triple. Those earnings gained 20/20 one and then of course Pfizer and by doing tech developed as highly effective vaccine in less than a year of feet than some expected. Could take as long as a decade.

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"1:14","description":"Drugmaker Pfizer expects $15 billion in revenue from its COVID-19 vaccine in 2021 and said it can produce 2 billion doses this year, including 200 million doses for the U.S.","mediaType":"default","section":"ABCNews/Business","id":"75645645","title":"By the Numbers: Pfizer’s $15 billion payday","url":"/Business/video/numbers-pfizers-15-billion-payday-75645645"}